TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Lung Kee (Bermuda) Holdings Limited ( (HK:0255) ) has provided an announcement.
Lung Kee (Bermuda) Holdings Limited announced its interim financial results for the six months ending June 30, 2025, revealing a decrease in revenue to HK$688,654,000 from HK$785,212,000 in the previous year. Despite the revenue drop, the company reported a reduced loss before taxation of HK$1,865,000 compared to HK$27,757,000 in 2024, indicating improved operational efficiency. The total comprehensive income for the period was HK$40,380,000, a significant recovery from the previous year’s comprehensive expense of HK$63,300,000, largely due to favorable exchange differences.
The most recent analyst rating on (HK:0255) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Lung Kee (Bermuda) Holdings Limited stock, see the HK:0255 Stock Forecast page.
More about Lung Kee (Bermuda) Holdings Limited
Lung Kee (Bermuda) Holdings Limited operates in the manufacturing industry, focusing on the production of mold bases and related components. The company serves a variety of markets, primarily targeting the manufacturing sector with its specialized products.
Average Trading Volume: 95,889
Technical Sentiment Signal: Buy
Current Market Cap: HK$972.8M
For an in-depth examination of 0255 stock, go to TipRanks’ Overview page.